13. Tepper RI, Pattengale PK, Leder P. Murine interleukin-4 displays potent anti-tumor activity in 
vivo. Cell 57:503-512, 1989. 
14. Rosenberg SA, Aebersold P, Cometta K, et al. Gene transfer into humans - immunotherapy of 
patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene 
transduction. N Eng J Med 323:570-578, 1990. 
15. Miller AD, and Rosman GJ. Improved retroviral vectors for gene transfer and expression. 
BioTechniques 7:980, 1989. 
16. Mahaley MS, Bigner DD, Dudka LF, Wilds PR, Williams DH, Bouldin TW, Whitaker JN, Bynum 
JM. Immunobiology of primary intracranial tumors. JNeurosurg 59, 201-207, 1983. 
17. Holladay FP, Heitz T, Wood GW. Cytotoxic T lymphocytes, but not lymphokine activated killer 
cells, exhibit anti-tumor activity against established intracerebral gliomas. J. Neurosurg,. 77:757, 1992. 
18. Trojan, J., Johnson, T.R., Rudin, S.D., Han, J., Tykocinski, M.L. and Han, J. Treatment and 
prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I 
RNA. Science, 259(5091):94-97, 1993. 
19. Kruse et al., Interleukin-2 activated lymphocytes from brain tumor patients. Cancer 64:1629, 
1989 
20. Kruse et al.. Systemic chemotherapy combined with local adoptive immunotherapy cures rats 
bearing 9L gliosarcoma. JNeuro-Oncol 15:97,1993 
Recombinant DNA Research, Volume 19 
[633] 
